NASDAQ:CRMD
CorMedix Inc. (CRMD)
Financials 
Technical Analysis 
Jul 24, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
CorMedix Inc. (CRMD-Q) has recently received mixed reviews from stock analysts. Michael O'Reilly, a Stockchase Research Editor, indicated that the stock has experienced a significant downturn of 25.7% since its past top pick status. Despite this, the company is reportedly beginning to see positive results from its innovative antimicrobial catheter lock, which is the first of its kind in the healthcare industry and has been proven to reduce infection rates by over 70%. This new product is considered a major cost-saving measure for health plans. The stock currently trades at a price-to-earnings ratio of 17x, a price-to-book ratio of 4x, and has an impressive return on equity of 38%. With a recommended upside potential of 28% and an analyst price target of $19.50, the stock's current valuation may suggest opportunity for investors, although a cautious approach with a stop-loss at $9.50 is advised.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
Premium contentCRMD is beginning to see fruit of its antimicrobial catheter lock -- the first and only in the heath space introduced in last year -- that has been clinically proven to reduce infection by over 70% (a BIG cost saver to health plans). It trades at 17x earnings, 4x book and supports a robust 38% ROE. We recommend setting a stop-loss at $9.50, looking to achieve $17.00 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $19.50)- «
- ‹
- 1
- ›
- »
Popular Articles
CorMedix Inc. (CRMD) Frequently Asked Questions
What is CorMedix Inc. stock symbol?
CorMedix Inc. is a American stock, trading under the symbol CRMD (previously CRMD-Q on Stockchase) on the NASDAQ (CRMD). It is usually referred to as NASDAQ:CRMD or CRMD
Is CorMedix Inc. a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on CRMD (previously CRMD-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is PAST TOP PICK. Read the latest stock experts' ratings for CorMedix Inc..
Is CorMedix Inc. a good investment or a top pick?
CorMedix Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2025-11-25. Read the latest stock experts ratings for CorMedix Inc..
Why is CorMedix Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for CorMedix Inc..
Is CorMedix Inc. worth watching?
CorMedix Inc. is covered by Stockchase experts and is worth watching.
What is CorMedix Inc. stock price?
On 2026-07-24, CorMedix Inc. (CRMD) stock closed at a price of $7.87.
Our PAST TOP PICK with CRMD has triggered its stop at $9.50. To remain disciplined, we recommend covering the position at this time.